NIR quantitative phase imaging enables label-free cell imaging through silicon

A team of scientists from the University of Texas at Arlington and the Massachusetts Institute of Technology (MIT; Cambridge, MA) has figured out how to quantitatively observe cellular processes taking place on lab-on-a-chip devices in a silicon environment. The new technology will be useful in drug development as well as in disease diagnosis, the researchers say.

In a paper published in Nature's online journal Scientific Reports, the team said it overcame past limitations on quantitative microscopy through an opaque media by working with a new combination of near-infrared (NIR) light and a technique called quantitative phase imaging. A decade-old technique, quantitative phase imaging uses shifts in phases of light, not staining techniques, to aid specimen imaging—hence the term "€œlabel-free."

Related: Shining near-infrared light on life

"To the best of our knowledge, this is the first demonstration of quantitative phase imaging of cellular structure and function in silicon environment,"€ says Assistant Professor of Physics Samarendra Mohanty, head of the Biophysics and Physiology Laboratory at UT Arlington and corresponding author on the paper.  

The research team was able to prove success in analyzing specimens through a silicon wafer in two instances. In one, they accomplished full-field imaging of the features of red blood cells to nanometer-thickness accuracy. In another, they observed dynamic variation of human embryonic kidney cells in response to change in salt concentration. Mohanty believes that his group'€™s current work on NIR quantitative phase imaging can lead to noninvasive, label-free monitoring of neuronal activities.

"€œSilicon-based micro devices known as labs-on-a-chip are revolutionizing high throughput analysis of cells and molecules for disease diagnosis and screening of drug effects. However, very little progress has been made in the optical characterization of samples in these systems,"€ says Bipin Joshi, a recent graduate and lead author on the paper. "The technology we'€™ve developed is well suited to meet this need."

Ishan Barman, now an assistant professor at Johns Hopkins University, said the new paper is a prime example of the type of research he hopes to do—€”projects pulled by needs of the biomedical community and continually pushing the edge of biophotonic solutions.

"€œWe envision that this significantly expands the visualization possible in silicon based microelectronic and micromechanical devices,"€ he says.

Full details of the work appear in Scientific Reports; for more information, please visit http://www.nature.com/srep/2013/131002/srep02822/full/srep02822.html.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

POST A COMMENT

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Exposure to bright blue light during meals increases insulin resistance

Bright blue light exposure increased insulin resistance compared to dim light exposure in both the morning and the evening.

MRI-guided laser ablation shows promise for prostate cancer treatment

Focal laser ablation is both feasible and safe in men with intermediate-risk prostate cancer.

Biophotonics: PIX4life targets biophotonics with visible-range PICs, development capacity build

Photonics has become critical to life sciences -- however, the field is far from benefiting fully from photonics' capabilities.

Tiny OCT retinal scanner could diagnose blindness early

A compact, cost-effective retinal scanner that uses OCT imaging to diagnose retinal diseases early is being developed.

Sensor pairing two optical methods shows promise for high-speed disease detection

A highly sensitive sensor that combines two optical methods could enable new high-speed disease detection.

FDA approves at-home laser therapy device to treat male and female hair loss

The FDA has cleared Capillus' low-level laser therapy Capillus caps for treating androgenetic alopecia in both men and women.

Biophotonics-enabled device could eliminate unnecessary thyroid nodule surgery

A portable biophotonics-enabled device could reduce invasive procedures in treating potentially cancerous thyroid nodules.

New acquisition has goal of developing laser-based cancer proton therapy system

HIL Applied Medical has acquired Nanolabz, which develops and fabricates smart targets for laser-based proton acceleration.

Optovue OCT retinal imaging system is available commercially

OCT and OCT angiography system developer Optovue has released its AngioVue Retina imaging system commercially.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS